There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Latin America is estimated to have 3637 cases of meningitis, 14,548 cases of bacteremia,
192,761-318,238 cases of pneumonia, and about 5.6 million cases of otitis media annually.
Pneumococcal conjugate vaccines (PCVs) have proven to be effective in preventing paediatric
pneumococcal disease. Monitoring serotypes and anti-microbial resistance in Latin
American children by collecting clinical and epidemiological data at regular intervals
is essential. It is important to identify and support systems for surveillance of
invasive pneumococcal disease based on population to demonstrate the impact of PCVs.
Surveillance should include pneumococcal disease in adults to estimate the indirect
effects of the vaccine.